FP05.03 Multiomic, Plasma-Only ctDNA NGS Assay Developed for Minimal Residual Disease (MRD) Detection in Early-Stage NSCLC

Authors :: T. Dinman
D. Cheng
Kimberly C. Banks
D. Hite
Kristin Price
J. Kurata
AmirAli Talasaz
P. Parsana
E. Zotenko
J. Ju
Z. Miao
Source :: Journal of Thoracic Oncology. 16:S952-S953
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
Internal medicine
Medicine
Stage (cooking)
business
Minimal residual disease

Tools